Position in ABBV
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$407,937,369
+$80,313,703 QoQ
Shares Held
1,621,115
+7.6% QoQ
Ownership
0.092%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
#95
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 76%
Shared 0%
None 24%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Russell Investments Group, Ltd. holds $3,483,940,248 across 16 Drug Manufacturers - General names. ABBV ranks #3 (11.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
781,929 | $937,869,169 | |
| 2 | JNJ |
Johnson & Johnson
|
2,675,500 | $679,496,724 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
1,621,115 | $407,937,369 | |
| 4 | AZN |
Astrazeneca PLC
|
2,033,587 | $385,608,756 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,578,024 | $331,276,081 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
4,215,423 | $242,892,664 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
1,070,731 | $135,276,147 | |
| 8 | PFE |
Pfizer Inc
|
5,482,863 | $132,027,333 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $407,937,369 | 1,621,115 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $327,623,666 | 1,506,385 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $315,952,079 | 1,382,783 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $311,845,475 | 1,346,832 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $216,689,440 | 1,167,382 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $241,090,888 | 1,150,682 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $211,336,117 | 1,189,286 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $227,220,879 | 1,150,602 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $183,167,405 | 1,067,907 | Shares | Defined | 2024-08-08 | |
| 2024-03-31 | $196,120,058 | 1,076,991 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $163,717,743 | 1,056,448 | Shares | Defined | 2024-02-05 | |
| 2023-09-30 | $144,450,763 | 969,078 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $117,723,029 | 873,770 | Shares | Defined | 2023-08-10 | |
| 2023-03-31 | $136,998,273 | 859,624 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $136,611,515 | 845,316 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $123,355,761 | 919,125 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $133,000,772 | 868,378 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $138,205,417 | 852,541 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $140,537,073 | 1,037,940 | Shares | Defined | 2022-01-21 | |
| 2021-09-30 | $118,306,526 | 1,096,751 | Shares | Defined | 2021-11-08 | |
| 2021-06-30 | $133,378,147 | 1,184,110 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $152,727,635 | 1,411,270 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $165,217,367 | 1,541,926 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $161,493,357 | 1,843,742 | Shares | Defined | 2020-11-09 | |
| 2020-06-30 | $191,165,980 | 1,947,097 | Shares | Defined | 2020-08-05 | |
| 2020-03-31 | $195,546,659 | 2,566,566 | Shares | Defined | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||